Not recruiting yet
One-stop Diagnosis and Treatment for Suspected Lung Cancer: Combined RBS, nClE, OBCT and Ablation
NCT07521618 · Guangzhou Medical University · Updated 13 April 2026
- What is being tested
- Ablation
- For
- Lung Cancer (Suspected or Confirmed); Cryoablation; Robotic Bronchoscopy System; Confocal Laser Endomicroscopy
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 30 people. The full rules are on the registry page.
- Where
- Not stated
- When
- Starts or started 1 April 2026, ends 31 Dec 2026. Registered 13 April 2026.
- Results
- None posted yet.
In the researchers' words
Using RBS as the navigation and treatment platform, precisely navigate to the target lesion. Utilize r-EUBS and nCLE to identify the lesion, and when the confocal AI model recognizes the lesion as malignant, perform a biopsy. Subsequently, under the guidance of OBCT, carry out ablation treatment of the lesion.
